All PlansAdministrativeMedium impact
Newsletter Vol. 10, No. 35
New Jersey Medicaid·NJ · Pulmonology, Allergy & Immunology, Family Medicine +2 more·Provider Notice
We identified it
Jun 20, 2026
Summary
New policy implements pharmaceutical dosage unit ratio (PDUR) monitoring for inhaler medications based on additional maximum daily dosage standards. This will likely affect billing and prior authorization requirements for inhaler prescriptions and related respiratory treatments.
Action Required
Review the full Newsletter Vol. 10, No. 35 document at the provided URL to understand specific PDUR monitoring requirements for pharmaceutical inhalers. Update billing workflows to accommodate any new dosage verification or prior authorization requirements that may result from this monitoring program.